A detailed history of Voya Investment Management LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 30,232 shares of COGT stock, worth $243,669. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,232
Previous 30,823 1.92%
Holding current value
$243,669
Previous $259,000 25.87%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.24 - $11.48 $4,869 - $6,784
-591 Reduced 1.92%
30,232 $326,000
Q2 2024

Dec 03, 2024

BUY
$6.01 - $9.04 $3,551 - $5,342
591 Added 1.95%
30,823 $259,000
Q2 2024

Aug 14, 2024

BUY
$6.01 - $9.04 $21,053 - $31,667
3,503 Added 12.82%
30,823 $259,000
Q1 2024

Dec 06, 2024

SELL
$4.38 - $9.02 $12,754 - $26,266
-2,912 Reduced 9.63%
27,320 $183,000
Q1 2024

May 15, 2024

SELL
$4.38 - $9.02 $23,984 - $49,393
-5,476 Reduced 16.7%
27,320 $183,000
Q4 2023

Feb 14, 2024

BUY
$4.06 - $10.08 $1,814 - $4,505
447 Added 1.38%
32,796 $192,000
Q3 2023

Nov 14, 2023

BUY
$9.69 - $13.34 $48,062 - $66,166
4,960 Added 18.11%
32,349 $315,000
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.24 $28,939 - $38,899
2,938 Added 12.02%
27,389 $324,000
Q3 2022

Nov 14, 2022

BUY
$9.39 - $16.99 $71,579 - $129,514
7,623 Added 45.3%
24,451 $365,000
Q2 2022

Aug 15, 2022

BUY
$3.92 - $9.73 $7,902 - $19,615
2,016 Added 13.61%
16,828 $152,000
Q4 2021

Feb 14, 2022

SELL
$7.51 - $10.81 $1,081 - $1,556
-144 Reduced 0.96%
14,812 $127,000
Q2 2021

Aug 16, 2021

BUY
$7.82 - $9.3 $116,955 - $139,090
14,956 New
14,956 $121,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $530M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.